John Oyler is Chief Executive Officer of BeiGene, Ltd.. Currently has a direct ownership of 0 shares of BGNE, which is worth approximately $0. The most recent transaction as insider was on Jun 17, 2025, when has been sold 1,460 shares (American Depositary Shares) at a price of $256.49 per share, resulting in proceeds of $374,475. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

JOHN OYLER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 17 2025
SELL
Open market or private sale
$374,475 $256.49 p/Share
1,460 Reduced 100.0%
0 American Depositary Sh...
Jun 16 2025
SELL
Open market or private sale
$979,064 $266.05 p/Share
3,680 Reduced 71.6%
1,460 American Depositary Sh...
Jun 10 2025
BUY
Grant, award, or other acquisition
-
185,055 Added 2.19%
8,281,841 Ordinary Shares
Jun 06 2025
SELL
Open market or private sale
$1,299,079 $253.38 p/Share
5,127 Reduced 100.0%
0 American Depositary Sh...
May 09 2025
SELL
Payment of exercise price or tax liability
$35,532,263 $17.85 p/Share
1,990,603 Reduced 19.6%
8,163,437 Ordinary Shares
May 09 2025
BUY
Exercise of conversion of derivative security
$2,027,707 $0.5 p/Share
4,055,415 Added 28.54%
10,154,040 Ordinary Shares
Mar 10 2025
SELL
Open market or private sale
$10,010,321 $242.91 p/Share
41,210 Reduced 100.0%
0 American Depositary Sh...
Mar 10 2025
BUY
Exercise of conversion of derivative security
$267,865 $6.5 p/Share
41,210 Added 50.0%
41,210 American Depositary Sh...
Mar 10 2025
BUY
Exercise of conversion of derivative security
$248,911 $0.5 p/Share
497,822 Added 7.55%
6,098,625 Ordinary Shares
Mar 07 2025
SELL
Open market or private sale
$14,667,420 $250.34 p/Share
58,590 Reduced 100.0%
0 American Depositary Sh...
Mar 07 2025
BUY
Exercise of conversion of derivative security
$380,835 $6.5 p/Share
58,590 Added 50.0%
58,590 American Depositary Sh...
Mar 07 2025
BUY
Exercise of conversion of derivative security
$354,373 $0.5 p/Share
708,747 Added 11.23%
5,600,803 Ordinary Shares
Mar 06 2025
SELL
Open market or private sale
$10,447,592 $260.48 p/Share
40,109 Reduced 100.0%
0 American Depositary Sh...
Mar 06 2025
BUY
Exercise of conversion of derivative security
$260,708 $6.5 p/Share
40,109 Added 50.0%
40,109 American Depositary Sh...
Mar 06 2025
BUY
Exercise of conversion of derivative security
$243,080 $0.5 p/Share
486,161 Added 9.04%
4,892,056 Ordinary Shares
Mar 05 2025
BUY
Grant, award, or other acquisition
-
201,084 Added 4.36%
4,405,895 Ordinary Shares
Mar 03 2025
SELL
Open market or private sale
$24,742,980 $244.98 p/Share
101,000 Reduced 100.0%
0 American Depositary Sh...
Mar 03 2025
BUY
Exercise of conversion of derivative security
$656,500 $6.5 p/Share
101,000 Added 50.0%
101,000 American Depositary Sh...
Mar 03 2025
BUY
Exercise of conversion of derivative security
$610,265 $0.5 p/Share
1,220,531 Added 22.52%
4,199,364 Ordinary Shares
Dec 14 2024
BUY
Exercise of conversion of derivative security
$650,000 $0.5 p/Share
1,300,000 Added 30.38%
2,978,833 Ordinary Shares
Oct 08 2024
SELL
Open market or private sale
$1,437,354 $232.77 p/Share
6,175 Reduced 100.0%
0 American Depositary Sh...
Jun 24 2024
SELL
Open market or private sale
$445,710 $159.81 p/Share
2,789 Reduced 100.0%
0 American Depositary Sh...
Jun 17 2024
SELL
Open market or private sale
$204,037 $159.28 p/Share
1,281 Reduced 100.0%
0 American Depositary Sh...
Jun 05 2024
BUY
Grant, award, or other acquisition
-
490,464 Added 21.3%
1,812,018 Ordinary Shares
Mar 13 2024
SELL
Open market or private sale
$2,218,650 $179.91 p/Share
12,332 Reduced 100.0%
0 American Depositary Sh...
JO

John Oyler

Chief Executive Officer
Camana Bay, Grand Cayman, E9

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Track Activities on BGNE